CQS
ABCL icon

Credential Qtrade Securities’s AbCellera Biologics ABCL Stock Holding History

Credential Qtrade Securities’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-109
Closed -$1.08K – 339
2022
Q3 		$1.08K Hold
109
– – ﹤0.01% 360
2022
Q2 		$1.16K Hold
109
– – ﹤0.01% 343
2022
Q1 		$1.06K Hold
109
– – ﹤0.01% 345
2021
Q4 		$1.56K Hold
109
– – ﹤0.01% 348
2021
Q3 		$2.18K Sell
109
-26,450
-100% -$468K ﹤0.01% 330
2021
Q2 		$584K Buy
26,559
+26,450
+24,266% +$729K 0.05% 165
2021
Q1 		$3.7K Buy
+109
New +$4.34K ﹤0.01% 323

Other funds holding ABCL

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
HMC
Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
FFVM
Founders Fund VII Management San Francisco, California $2.03M AUM 72.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return